These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 30314337)

  • 1. Dysregulated Marginal Zone B Cell Compartment in a Mouse Model of Sjögren's Syndrome with Ocular Inflammation.
    Singh N; Chin I; Gabriel P; Blaum E; Masli S
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30314337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombospondin-derived peptide attenuates Sjögren's syndrome-associated ocular surface inflammation in mice.
    Contreras Ruiz L; Mir FA; Turpie B; Masli S
    Clin Exp Immunol; 2017 Apr; 188(1):86-95. PubMed ID: 28033649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central role for marginal zone B cells in an animal model of Sjogren's syndrome.
    Shen L; Gao C; Suresh L; Xian Z; Song N; Chaves LD; Yu M; Ambrus JL
    Clin Immunol; 2016 Jul; 168():30-36. PubMed ID: 27140729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sjögren's syndrome-like ocular surface disease in thrombospondin-1 deficient mice.
    Turpie B; Yoshimura T; Gulati A; Rios JD; Dartt DA; Masli S
    Am J Pathol; 2009 Sep; 175(3):1136-47. PubMed ID: 19700744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Covert Appearance of Marginal Zone B Cells in Salivary Glands of Sjögren's Syndrome-Susceptible Mice: Initiators of Subsequent Overt Clinical Disease.
    Peck AB; Nguyen CQ; Ambrus J
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of Aquaporins in the Pathogenesis, Diagnosis and Treatment of Sjögren's Syndrome.
    Soyfoo MS; Chivasso C; Perret J; Delporte C
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction of autophagy impairment inhibits pathology in the NOD.H-2h4 mouse model of primary Sjögren's syndrome.
    Voynova E; Lefebvre F; Qadri A; Muller S
    J Autoimmun; 2020 Mar; 108():102418. PubMed ID: 32029330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-chain fatty acid butyrate induces IL-10-producing B cells by regulating circadian-clock-related genes to ameliorate Sjögren's syndrome.
    Kim DS; Woo JS; Min HK; Choi JW; Moon JH; Park MJ; Kwok SK; Park SH; Cho ML
    J Autoimmun; 2021 May; 119():102611. PubMed ID: 33631650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotypic rheumatoid factors that are frequently expressed in mucosa-associated lymphoid tissue-type lymphomas are rare in the labial salivary glands of patients with Sjögren's syndrome.
    Bende RJ; Slot LM; Hoogeboom R; Wormhoudt TA; Adeoye AO; Guikema JE; van Noesel CJ
    Arthritis Rheumatol; 2015 Apr; 67(4):1074-83. PubMed ID: 25546553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ly9 (CD229) Antibody Targeting Depletes Marginal Zone and Germinal Center B Cells in Lymphoid Tissues and Reduces Salivary Gland Inflammation in a Mouse Model of Sjögren's Syndrome.
    Puñet-Ortiz J; Sáez Moya M; Cuenca M; Caleiras E; Lazaro A; Engel P
    Front Immunol; 2018; 9():2661. PubMed ID: 30519241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for lymphotoxin in primary Sjogren's disease.
    Shen L; Suresh L; Wu J; Xuan J; Li H; Zhang C; Pankewycz O; Ambrus JL
    J Immunol; 2010 Nov; 185(10):6355-63. PubMed ID: 20952683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A MZB Cell Activation Profile Present in the Lacrimal Glands of Sjögren's Syndrome-Susceptible C57BL/6.NOD-
    Peck AB; Nguyen CQ; Ambrus JL
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sjögren's syndrome: an old tale with a new twist.
    Lee BH; Tudares MA; Nguyen CQ
    Arch Immunol Ther Exp (Warsz); 2009; 57(1):57-66. PubMed ID: 19219532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological Analysis of Ocular Lesions in a Murine Model of Sjögren's Syndrome.
    Ushio A; Arakaki R; Eguchi H; Hotta F; Yamada A; Kudo Y; Ishimaru N
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-17 and CCR9
    Hwang SH; Woo JS; Moon J; Yang S; Park JS; Lee J; Choi J; Lee KH; Kwok SK; Park SH; Cho ML
    Front Immunol; 2021; 12():721453. PubMed ID: 34539657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TSP-1 Deficiency Alters Ocular Microbiota: Implications for Sjögren's Syndrome Pathogenesis.
    Terzulli M; Contreras-Ruiz L; Kugadas A; Masli S; Gadjeva M
    J Ocul Pharmacol Ther; 2015 Sep; 31(7):413-8. PubMed ID: 26352162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marginal Zone B (MZB) Cells: Comparison of the Initial Identification of Immune Activity Leading to Dacryoadenitis and Sialadenitis in Experimental Sjögren's Syndrome.
    Peck AB; Ambrus JL
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lacrimal and salivary gland inflammation in the C3H/Ipr autoimmune strain mouse: a potential mode for Sjögren's syndrome.
    Johnson BC; Morton JI; Trune DR
    Otolaryngol Head Neck Surg; 1992 Apr; 106(4):394-9. PubMed ID: 1565490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The T cell in Sjogren's syndrome: force majeure, not spectateur.
    Singh N; Cohen PL
    J Autoimmun; 2012 Sep; 39(3):229-33. PubMed ID: 22709856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of transitional type II B cells in the salivary glands of patients with Sjögren's syndrome.
    Daridon C; Pers JO; Devauchelle V; Martins-Carvalho C; Hutin P; Pennec YL; Saraux A; Youinou P
    Arthritis Rheum; 2006 Jul; 54(7):2280-8. PubMed ID: 16802367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.